title: Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
abstract: The worldwide epidemic of obesity and insulin resistance favors nonalcoholic fatty liver disease (NAFLD). Insulin resistance (IR) in the adipose tissue increases lipolysis and the entry of nonesterified fatty acids (NEFAs) in the liver, whereas IR-associated hyperinsulinemia promotes hepatic de novo lipogenesis. However, several hormonal and metabolic adaptations are set up in order to restrain hepatic fat accumulation, such as increased mitochondrial fatty acid oxidation (mtFAO). Unfortunately, these adaptations are usually not sufficient to reduce fat accumulation in liver. Furthermore, enhanced mtFAO without concomitant up-regulation of the mitochondrial respiratory chain (MRC) activity induces reactive oxygen species (ROS) overproduction within different MRC components upstream of cytochrome c oxidase. This event seems to play a significant role in the initiation of oxidative stress and subsequent development of nonalcoholic steatohepatitis (NASH) in some individuals. Experimental investigations also pointed to a progressive reduction of MRC activity during NAFLD, which could impair energy output and aggravate ROS overproduction by the damaged MRC. Hence, developing drugs that further increase mtFAO and restore MRC activity in a coordinated manner could ameliorate steatosis, but also necroinflammation and fibrosis by reducing oxidative stress. In contrast, physicians should be aware that numerous drugs in the current pharmacopoeia are able to induce mitochondrial dysfunction, which could aggravate NAFLD in some patients.
authors.affiliation: INSERM, U991, Université de Rennes 1, Rennes, France.
authors.forename: Karima
authors.initials: K
authors.lastname: Begriche
authors.forename: Julie
authors.initials: J
authors.lastname: Massart
authors.forename: Marie-Anne
authors.initials: MA
authors.lastname: Robin
authors.forename: Fabrice
authors.initials: F
authors.lastname: Bonnet
authors.forename: Bernard
authors.initials: B
authors.lastname: Fromenty
mesh_terms: D000222:Adaptation, Physiological / Q000502:physiology*; D000818:Animals; D004195:Disease Models, Animal; D004734:Energy Metabolism / Q000502:physiology; D005234:Fatty Liver / Q000503:physiopathology*; D006801:Humans; D050356:Lipid Metabolism / Q000502:physiology; D008099:Liver / Q000378:metabolism; D008930:Mitochondria, Liver / Q000502:physiology*; D065626:Non-alcoholic Fatty Liver Disease